LINDSAY GUTIERREZ: Open Payments
NPI 1396150090 · EMPORIA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$382 in 14 payments from 6 companies in 2025. Trend: 2023 $316 · 2024 $93 · 2025 $382
Food & beverage: $382
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $102 |
| Otsuka America Pharmaceutical, Inc. | 5 | $97 |
| E.R. Squibb & Sons, L.L.C. | 2 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $49 |
| Alkermes, Inc. | 2 | $41 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
Products named: VRAYLAR, COBENFY, REXULTI, AUSTEDO XR, ARISTADA, ABILIFY MAINTENA, HETLIOZ.
Industry payments across KS — which companies pay providers there.
